| Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa S Parikh, JB Ouedraogo, JA Goldstein, PJ Rosenthal, DL Kroetz Clinical Pharmacology & Therapeutics 82 (2), 197-203, 2007 | 193 | 2007 |
| Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors S Parikh, J Gut, E Istvan, DE Goldberg, DV Havlir, PJ Rosenthal Antimicrobial agents and chemotherapy 49 (7), 2983-2985, 2005 | 186 | 2005 |
| Effectiveness of the Pfizer-BioNTech COVID-19 vaccine among residents of two skilled nursing facilities experiencing COVID-19 outbreaks—Connecticut, December 2020–February 2021 A Britton MMWR. Morbidity and mortality weekly report 70, 2021 | 177 | 2021 |
| Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria J Tarning, I Zongo, FA Some, N Rouamba, S Parikh, PJ Rosenthal, ... Clinical Pharmacology & Therapeutics 91 (3), 497-505, 2012 | 139 | 2012 |
| Biochemical and immunological mechanisms by which sickle cell trait protects against malaria L Gong, S Parikh, PJ Rosenthal, B Greenhouse Malaria journal 12, 1-9, 2013 | 125 | 2013 |
| Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial BD Foy, H Alout, JA Seaman, S Rao, T Magalhaes, M Wade, S Parikh, ... The Lancet 393 (10180), 1517-1526, 2019 | 123 | 2019 |
| Time series analysis of malaria in Afghanistan: using ARIMA models to predict future trends in incidence MY Anwar, JA Lewnard, S Parikh, VE Pitzer Malaria journal 15, 1-10, 2016 | 115 | 2016 |
| Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda J Mwesigwa, S Parikh, B McGee, P German, T Drysdale, JN Kalyango, ... Antimicrobial agents and chemotherapy 54 (1), 52-59, 2010 | 108 | 2010 |
| Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers P German, S Parikh, J Lawrence, G Dorsey, PJ Rosenthal, D Havlir, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (4), 424-429, 2009 | 98 | 2009 |
| Malaria diagnostics in clinical trials SC Murphy, JP Shott, S Parikh, P Etter, WR Prescott, VA Stewart The American journal of tropical medicine and hygiene 89 (5), 824, 2013 | 92 | 2013 |
| Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility MK Johnson, TD Clark, D Njama-Meya, PJ Rosenthal, S Parikh PloS one 4 (9), e7246, 2009 | 89 | 2009 |
| Population pharmacokinetic properties of piperaquine in falciparum malaria: an individual participant data meta-analysis RM Hoglund, L Workman, MD Edstein, NX Thanh, NN Quang, I Zongo, ... PLoS medicine 14 (1), e1002212, 2017 | 79 | 2017 |
| Host polymorphisms and the incidence of malaria in Ugandan children S Parikh, G Dorsey, PJ Rosenthal The American journal of tropical medicine and hygiene 71 (6), 750-753, 2004 | 71 | 2004 |
| Molecular evaluation of the natural history of asymptomatic parasitemia in Ugandan children SL Nsobya, S Parikh, F Kironde, G Lubega, MR Kamya, PJ Rosenthal, ... The Journal of infectious diseases 189 (12), 2220-2226, 2004 | 66 | 2004 |
| Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether–lumefantrine in healthy volunteers L Huang, S Parikh, PJ Rosenthal, P Lizak, F Marzan, G Dorsey, D Havlir, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 61 (3), 310-316, 2012 | 58 | 2012 |
| In vitro metabolism of piperaquine is primarily mediated by CYP3A4 TMN Lee, L Huang, MK Johnson, P Lizak, D Kroetz, F Aweeka, S Parikh Xenobiotica 42 (11), 1088-1095, 2012 | 55 | 2012 |
| Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: a pharmacokinetic-pharmacodynamic meta-analysis F Kloprogge, L Workman, S Borrmann, M Tékété, G Lefèvre, K Hamed, ... PLoS medicine 15 (6), e1002579, 2018 | 53 | 2018 |
| Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin S Parikh, J Liu, P Sijwali, J Gut, DE Goldberg, PJ Rosenthal Antimicrobial agents and chemotherapy 50 (6), 2207-2209, 2006 | 48 | 2006 |
| Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis B Ley, A Winasti Satyagraha, H Rahmat, ME von Fricken, NM Douglas, ... PLoS medicine 16 (12), e1002992, 2019 | 47 | 2019 |
| Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data … M Saito, R Mansoor, K Kennon, AR Anvikar, EA Ashley, D Chandramohan, ... The Lancet Infectious Diseases 20 (8), 943-952, 2020 | 42 | 2020 |
Philip RosenthalProfessor of Pediatrics & Surgery, University of CA an Francisco在 peds.ucsf.edu 的电子邮件经过验证
